2018 Generic Drug Competitive Intelligence: Sun Pharma Performance, Capabilities, Goals and Strategies
This report is part of the Competitive Analysis Series, which includes current assessments of more than 1,000 companies worldwide. The assessments include all or some of the following: Organization and Management, Acquisitions and Divestitures, Facilities and Employees, Research and Development, Technological Know-How, Key Products, Marketing Capabilities, Financial Results, Strengths and Weaknesses, and Strategic Direction.
The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs.
In dynamic and fragmented industries, besieged by intense competition and rapid change of technological innovations, the ability to anticipate new product introductions and marketing strategies is particularly important...and can spell the difference between success and failure.
The reports objectives include:
- To help current suppliers realistically assess their financial, technological and marketing capabilities vis--vis its competitors.
- To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates.
- To complement the organizations internal competitor information gathering efforts with strategic analysis, data interpretation and insight.
- To identify least competitive market niches with significant growth potential.
Several significant developments have aided and accelerated development and growth of markets in biotechnology, in the period of review. Notable recent advancements in biotechnology are CRISPR, Spheroids for drug development,View Report
Report ScopeThis report represents a current and important business tool to evaluate terms and conditions of licensing, acquisitions and partnerships deals in the biomarker sector. The geographic scope of thisView Report
Global Generic Drugs Market, By Type (Small Molecule Generics vs Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others), By Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House vs Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Company, By Region, Forecast & Opportunities, 2026
Global generic drugs market was valued at USD371.04 billion in 2020 and is anticipated to reach USD564.43 billion until 2026 by witnessing a CAGR of 7.08% during the forecast period.View Report
2021 Leading Generic Drug Companies SWOT Analysis--Capabilities, Goals and Strategies market research report available in single user pdf license with Aarkstore Enterprise at USD 4500View Report
Fill The Form For Sample Request